The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization

BACKGROUND/AIMS: The Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 and modified RECIST (mRECIST) criteria have been used to assess treatment responses for hepatocellular carcinoma (HCC) patients. We investigated which criteria provides better survival predictions in HCC patients treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jae Seung, Choi, Hong Jun, Kim, Beom Kyung, Park, Jun Yong, Kim, Do Young, Ahn, Sang Hoon, Han, Kwang-Hyub, Baek, Song-Ee, Chung, Yong Eun, Park, Mi-Suk, Kim, Myeong-Jin, Rhee, Hyungjin, Kim, Seung Up
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667935/
https://www.ncbi.nlm.nih.gov/pubmed/32050313
http://dx.doi.org/10.5009/gnl19197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667935/
https://www.ncbi.nlm.nih.gov/pubmed/32050313
http://dx.doi.org/10.5009/gnl19197

Ejemplares similares